SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-12-000090
Filing Date
2012-03-21
Accepted
2012-03-21 18:10:22
Documents
2
Period of Report
2012-03-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3826
2 attach_1.htm EX-24 1018
  Complete submission text file 0001012975-12-000090.txt   6344
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NEW LEAF VENTURES 2500 SAND HILL ROAD, SUITE 203 MENLO PARK CA 94025
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 12707159